AIRLINK 175.73 Decreased By ▼ -2.19 (-1.23%)
BOP 13.12 Increased By ▲ 0.24 (1.86%)
CNERGY 7.54 Decreased By ▼ -0.04 (-0.53%)
FCCL 43.91 Decreased By ▼ -2.08 (-4.52%)
FFL 15.01 Decreased By ▼ -0.15 (-0.99%)
FLYNG 26.90 Decreased By ▼ -0.44 (-1.61%)
HUBC 130.23 Decreased By ▼ -1.81 (-1.37%)
HUMNL 13.34 Increased By ▲ 0.05 (0.38%)
KEL 4.50 Increased By ▲ 0.04 (0.9%)
KOSM 6.06 No Change ▼ 0.00 (0%)
MLCF 56.03 Decreased By ▼ -0.60 (-1.06%)
OGDC 214.77 Decreased By ▼ -9.07 (-4.05%)
PACE 5.98 Decreased By ▼ -0.01 (-0.17%)
PAEL 40.90 Decreased By ▼ -0.61 (-1.47%)
PIAHCLA 16.32 Increased By ▲ 0.31 (1.94%)
PIBTL 9.75 Decreased By ▼ -0.13 (-1.32%)
POWER 11.76 Increased By ▲ 0.60 (5.38%)
PPL 181.48 Decreased By ▼ -5.15 (-2.76%)
PRL 34.22 Decreased By ▼ -0.68 (-1.95%)
PTC 23.06 Decreased By ▼ -0.47 (-2%)
SEARL 95.72 Increased By ▲ 0.76 (0.8%)
SILK 1.14 No Change ▼ 0.00 (0%)
SSGC 35.45 Decreased By ▼ -0.05 (-0.14%)
SYM 15.75 Increased By ▲ 0.11 (0.7%)
TELE 7.87 No Change ▼ 0.00 (0%)
TPLP 10.98 Increased By ▲ 0.05 (0.46%)
TRG 60.50 Increased By ▲ 1.30 (2.2%)
WAVESAPP 10.81 Increased By ▲ 0.03 (0.28%)
WTL 1.35 No Change ▼ 0.00 (0%)
YOUW 3.77 Decreased By ▼ -0.03 (-0.79%)
AIRLINK 175.73 Decreased By ▼ -2.19 (-1.23%)
BOP 13.12 Increased By ▲ 0.24 (1.86%)
CNERGY 7.54 Decreased By ▼ -0.04 (-0.53%)
FCCL 43.91 Decreased By ▼ -2.08 (-4.52%)
FFL 15.01 Decreased By ▼ -0.15 (-0.99%)
FLYNG 26.90 Decreased By ▼ -0.44 (-1.61%)
HUBC 130.23 Decreased By ▼ -1.81 (-1.37%)
HUMNL 13.34 Increased By ▲ 0.05 (0.38%)
KEL 4.50 Increased By ▲ 0.04 (0.9%)
KOSM 6.06 No Change ▼ 0.00 (0%)
MLCF 56.03 Decreased By ▼ -0.60 (-1.06%)
OGDC 214.77 Decreased By ▼ -9.07 (-4.05%)
PACE 5.98 Decreased By ▼ -0.01 (-0.17%)
PAEL 40.90 Decreased By ▼ -0.61 (-1.47%)
PIAHCLA 16.32 Increased By ▲ 0.31 (1.94%)
PIBTL 9.75 Decreased By ▼ -0.13 (-1.32%)
POWER 11.76 Increased By ▲ 0.60 (5.38%)
PPL 181.48 Decreased By ▼ -5.15 (-2.76%)
PRL 34.22 Decreased By ▼ -0.68 (-1.95%)
PTC 23.06 Decreased By ▼ -0.47 (-2%)
SEARL 95.72 Increased By ▲ 0.76 (0.8%)
SILK 1.14 No Change ▼ 0.00 (0%)
SSGC 35.45 Decreased By ▼ -0.05 (-0.14%)
SYM 15.75 Increased By ▲ 0.11 (0.7%)
TELE 7.87 No Change ▼ 0.00 (0%)
TPLP 10.98 Increased By ▲ 0.05 (0.46%)
TRG 60.50 Increased By ▲ 1.30 (2.2%)
WAVESAPP 10.81 Increased By ▲ 0.03 (0.28%)
WTL 1.35 No Change ▼ 0.00 (0%)
YOUW 3.77 Decreased By ▼ -0.03 (-0.79%)
BR100 12,054 Decreased By -76.5 (-0.63%)
BR30 36,467 Decreased By -778.6 (-2.09%)
KSE100 114,356 Decreased By -42.4 (-0.04%)
KSE30 35,347 Decreased By -110.8 (-0.31%)
World

Indonesian clerics declare Sinovac's COVID-19 vaccine halal

  • Vaccination programme set to start next week.
  • Emergency use authorisation yet to be issued.
  • Indonesia records over 10,000 daily cases for first time.
  • Indonesia's 808,000 cases among Asia's highest.
Published January 8, 2021

JAKARTA: A COVID-19 vaccine produced by Sinovac Biotech is deemed halal, or permissible under Islam, the Indonesian Ulema Council said on Friday, days before the country is scheduled to start its inoculation programme using the Chinese vaccine.

Indonesia, the world's largest Muslim-majority country, has 3 million doses of CoronaVac and plans to use it when it starts its vaccination programme on Wednesday, with President Joko Widodo due to receive the first shot.

Asrorun Niam Sholeh of the council's fatwa commission told a news conference that Sinovac's CoronaVac was "holy and halal", although authorisation for its use still rests on Indonesia's food and drug agency (BPOM).

"This could be the information that could soothe the people, especially Muslims," Niam said.

Indonesia is struggling with the worst COVID-19 epidemic in Southeast Asia and authorities are relying on a vaccine to help alleviate the health and economic crises ravaging the country.

It confirmed a record daily rise in COVID-19 cases for the third consecutive day on Friday, reporting more than 10,000 daily infections for the first time and passing the 800,000 mark in cases, among the highest number in Asia.

It reported 10,617 new infections on Friday, taking total cases to 808,340. It has recorded 23,753 deaths.

Regulator BPOM has said it is hopeful that emergency use approval for CoronaVac, which depends on the results of the vaccine's Indonesian trials, will be issued before Wednesday.

CoronaVac was 78% effective in a late-stage Brazilian trial with no severe COVID-19 cases, researchers said on Thursday.

Comments

Comments are closed.